May 4, 2020
excitement about Gilead's Remdesivir, or at least Gilead's stock price
Before you get all excited about Drug company Gilead's Remdesivir as the miracle cure for the China Communist virus, consider the following:
The Clinical trials were rushed, and changed their primary outcome 1/2 way through from death/morbidity to 'time until clinical recovery', in order to report a positive finding. That is because the clinical trial for Remdesivir did not lower the death rate, it only lessened the time to recovery a little in patients who survived.
Acute Care Surgeon (and Asst Professor of Surgery at Wash U.) Mark Hoofnagle warns "I am truly sorry to say, Remdesivir is probably worthless..."
Cost is estimated at 750% what a flu shot costs.
At least Gilead's stock is trending up.
Maybe that's why Dr. Anthony Fauci is hopeful.
Meanwhile, 60% of all China Communist Virus deaths in MA are in Nursing Homes, where you are not allowed hydroxychloroquine because you can only get that if you are admitted to a Hospital.
Subscribe to:
Post Comments
(
Atom
)
1 comment :
Gilead Falls After Phase 3 Remdesivir 10-Day Trial Failed To Reach Significance
https://www.zerohedge.com/markets/gilead-announces-phase-3-remdesivir-results-did-not-find-statistically-significant
Post a Comment